Teva's Forum Draws Key Pennsylvania Healthcare Leaders
State Influentials Gather to Discuss the Rising Cost of Medicine for Consumers
PHILADELPHIA, July 30 /PRNewswire-USNewswire/ -- Teva
Pharmaceuticals USA, the world's leading generic pharmaceutical
company, today hosted the last in a series of roundtable
discussions focused on increasing access to healthcare and
affordable medicines in the United States.
The event was held as a part of the company's Year of Affordable
Healthcare Campaign (www.yearofaffordablehealth.com), which marks
the 25th anniversary of the passing of the Hatch-Waxman Act, a bill
which created the modern day pharmaceutical drug industry.
The event featured panelists from around the Philadelphia area,
all of whom have distinguished themselves by helping to bring
affordable healthcare solutions to the people of Pennsylvania. They
-- Thomas Snedden, Director, Pennsylvania Pharmaceutical Assistance Contract for the Elderly -- Pat Halpin-Murphy, President and Founder, Pennsylvania Breast Cancer Coalition -- Dr. Janet Young, Medical Director, Greater Philadelphia Health Action, Inc. -- Donna Duncan, Executive Director, Philadelphia's Linda Creed Breast Cancer Foundation
The panel was moderated by Pam Gilbert, partner at Cuneo Gilbert
& LaDuca and former executive director of the Consumer Product
"We are now at a crucial point in this debate," said Debra
Barrett, Senior Vice President of Government Affairs for Teva
Pharmaceuticals USA. "Healthcare costs continue to rise and
consumers in some cases are struggling to access care. We need to
ensure that affordable medicine options like biogenerics are
available, so that Pennsylvania citizens don't have to worry about
being able to afford their prescriptions."
The spirited discussion centered around the need for healthcare
reform, the steadily increasing costs of medicines and treatments
and potential solutions for these rising costs -- including the
development of a pathway for generic biologic medicines.
About Teva USA
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is
among the top 20 pharmaceutical companies in the world and is the
world's leading generic pharmaceutical company. The Company
develops, manufactures and markets generic and innovative human
pharmaceuticals and active pharmaceutical ingredients, as well as
animal health pharmaceutical products. Over 80 percent of Teva's
sales are in North America and Europe.
Source: Teva Pharmaceuticals USA
CONTACT: Denise Bradley of Teva Pharmaceuticals USA,
Web Site: http://www.yearofaffordablehealth.com
Posted: July 2009